Agenus / Antigenics (royalty heritage)

Listed in Lexington, United States.

Publicly reported facts

Location

Lexington, United States

Region

North America

Year founded

1994

Status

Active

Publicly listed

Yes · NASDAQ: AGEN

Case types

Biopharmaceutical royalty, Oncology IP, Drug patent licensing, Immunotherapy IP finance

Geographic coverage

Global

Industry associations

BIO

Website

agenusbio.com

Information as publicly reported; confirm terms directly with the funder. Criterica Capital does not endorse any listed funder.

Comparing funders? Criterica Capital publishes its pricing and gives decisions in 24 to 48 hours.